Sluggish response risks squandering historic opportunity to tackle global drug-resistant tuberculosis
3-20 | People living with MDR-TB and their healthcare providers call for urgent action
3-14 | “I felt like I had bugs crawling on the inside of my head”. The highly toxic pills and daily injections that Mary was taking made her vomit, lose her appetite and hallucinate. And it was MSF doctors who were telling her she had to keep on taking them, had to bear all those “side effects” in the hope that she would get well eventually. It took two years. But finally, Mary MARIZANI became the first MSF patient in Zimbabwe to be cured of multidrug resistant tuberculosis. “I had to pass through hell to get to heaven”.
1-2 | MSF calls for rapid registration in countries with high drug-resistant tuberculosis burdenMédecins Sans Frontières (MSF) welcomed the approval by the US Food and Drug Administration of bedaquiline, the first new drug active against tuberculosis (TB) to be registered since 1963.
11-15 | New MSF multinational study of paediatric TB/HIV co-infection confirms crisis of undiagnosed TB among childrenData from the largest-ever multinational cohort of children infected with both tuberculosis (TB) and HIV, released by the international medical humanitarian organisation Médecins Sans Frontières (MSF), shows there is an urgent need for better TB tests for children.
Implementation of new test increases drug-resistant TB diagnosis while shortening treatment initiation time
11-13 | Results from the largest multi-country implementation of the new rapid tuberculosis (TB) diagnostic test reveal an urgent need to address the growing global crisis of drug-resistant TB (DR-TB), according to the international medical humanitarian organisation Médecins Sans Frontières (MSF).